acrylamide has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cisneros, GA; Nochebuena, J | 1 |
| Barr, H; Cohen, G; Douangamath, A; Duberstein, S; Fearon, D; Filep, M; Gabizon, R; Gehrtz, P; London, N; Lukacik, P; Owen, CD; Prilusky, J; Resnick, E; Strain-Damerell, C; von Delft, F; Walsh, MA; Zaidman, D | 1 |
2 other study(ies) available for acrylamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Polarizable MD and QM/MM investigation of acrylamide-based leads to target the main protease of SARS-CoV-2.
Topics: Acrylamide; Coronavirus 3C Proteases; COVID-19; Cysteine Endopeptidases; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; Peptide Hydrolases; Protease Inhibitors; SARS-CoV-2; Viral Nonstructural Proteins | 2022 |
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M
Topics: Acrylamide; Binding Sites; Catalytic Domain; Computational Biology; COVID-19; Databases, Protein; Drug Design; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Protein Kinase Inhibitors; SARS-CoV-2; Viral Matrix Proteins | 2021 |